Effect of growth hormone administration on ICSI outcomes in patients with polycystic ovary syndrome and recurrent implantation failure: A retrospective cross‐over study

2020 ◽  
Author(s):  
Salvatore Giovanni Vitale ◽  
Marco Palumbo ◽  
Cristina Conde‐López ◽  
Nicolas Mendoza ◽  
Raquel Mendoza‐Tesarik ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Implantation Failure ◽  
Recurrent Implantation Failure ◽  
Ovary Syndrome ◽  
Growth Hormone Administration ◽  
Hormone Administration ◽  
Icsi Outcomes

Paradoxical Growth Hormone Response following Thyroid-Stimulating Hormone Administration in the Polycystic Ovary Syndrome

1989 ◽  
Vol 31 (3) ◽  
pp. 119-124 ◽  
Author(s):  
Margarita L.G. Anapliotou ◽  
Kostas Syrigos ◽  
George Panayiotakopoulos ◽  
Alexandros Kalos ◽  
Menelaos L. Batrinos
Keyword(s):  
Growth Hormone ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Thyroid Stimulating Hormone ◽  
Growth Hormone Response ◽  
Hormone Response ◽  
Ovary Syndrome ◽  
Hormone Administration ◽  
Paradoxical Growth ◽  
Stimulating Hormone

scholarly journals HOW POLYCYSTIC OVARY SYNDROME (PCOS) AFFECTS THE FERTILITY POTENTIAL OF REPRODUCTIVE AGE FEMALES: REVIEW

2019 ◽  
Vol 1 (2) ◽  
pp. 77-84
Keyword(s):  
Polycystic Ovary Syndrome ◽  
Embryonic Development ◽  
Polycystic Ovary ◽  
Reproductive Age ◽  
Implantation Failure ◽  
Ovary Syndrome ◽  
Young Females ◽  
Ovulatory Dysfunction ◽  
Hormonal Dysfunction ◽  
Fertility Potential

Polycystic ovary syndrome (PCOS) is one of the major causes of decreased fertility in young females. Multiple extra- and intra-ovarian factors which are worked together or separately are responsible for sub-fertility. However, still, ovulatory dysfunction is the cornerstone that occurs as a result of hormonal dysfunction and consequently affects oocytes' quality, embryonic development and finally, implantation failure with a significant number of females seek assisted reproduction for getting pregnancy.

scholarly journals Pioglitazone Treatment Increases Spontaneous Growth Hormone (GH) Secretion and Stimulated GH Levels in Polycystic Ovary Syndrome

2005 ◽  
Vol 90 (10) ◽  
pp. 5605-5612 ◽  
Author(s):  
Dorte Glintborg ◽  
René Klinkby Støving ◽  
Claus Hagen ◽  
Anne Pernille Hermann ◽  
Jan Frystyk ◽  
...  
Keyword(s):  
Growth Hormone ◽  
Polycystic Ovary Syndrome ◽  
Polycystic Ovary ◽  
Ovary Syndrome ◽  
Spontaneous Growth ◽  
Gh Secretion ◽  
Pioglitazone Treatment
Sign in / Sign up

Export Citation Format

Share Document